HRT Financial’s Kalaris Therapeutics KLRS Stock Holding History

HRT Financial’s Portfolio KLRS Stock Details KLRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$13K	Buy
2023 Q1	–	Sell
2022 Q4	$246K	Buy
2022 Q3	–	Sell
2022 Q2	$169K	Buy
2022 Q1	$93K	Buy
2021 Q3	–	Sell
2021 Q2	$1.58M	Buy